Oxford Nanopore Technolo... Share Discussion Threads

[brucie5] 01/5/2024 13:21

My feeling is that post Brexit, whether by correlation or causation, UK Plc is like the housing market in 1996. It's a buyer's market. And the tech crown jewels - with double discount of currency depreciation and LSE low value assumptions- are to had for peanuts.
Such things do change, though I fear UK will be out in the cold for a generation, and will lose a large section of its most promising growth companies.

[32v31today] 01/5/2024 11:42

I've never really put much weight behind this being taken out, but changed my view recently. It certainly adds a bit of jeopardy to selling to take a little profit. One of the big boy LSTools could acquire this for a rounding error and it would add a disproportionate amount of 'value'. They have the customers, routes to market, geographic footprint, synergy etc etc. Pre or post breakeven? Who knows. They won't want a business that's just going to burn through cash and destroy their own EBITDA, but I'd be doing some serious DD if I were a CEO. It's a high value space waiting to be dominated. Given the difficulty of building a start up to here, despite having the benefit of a very well funded (at the time ) cornerstone investor backing all the way, I would still have good confidence in GS pushing a very good deal.

[brucie5] 01/5/2024 09:53

Maybe start with the premise that this will be bought out in due course; it's just too enormous not to.
Add the expiry of LAT shares in June.
Whack in the 3.5% subscription by Biomerieux at 2.38 last October.
Sprinkle over with heavy director buys in the region of 1.30, or thereabouts; not to mention some recent light seasoning by a NED as reported this morning.
Heat up with the strategic ambiguity of the 15m reported last night.

It may go lower; it may not.

[tsmith2] 01/5/2024 09:27

Should get a holding statement one way or other?looking to buy

[brucie5] 01/5/2024 07:31

Small fry 23k, but every little helps.

[seball] 01/5/2024 07:07

More director buying... follow the money buy

[tsmith2] 01/5/2024 05:49

Given share price weakness would think it was a sellmay have cleared seller - let's see today

[bamboo2] 30/4/2024 23:25

Looking at prices over the past few trading days, this is likely a late reported trade from Friday and could therefore equally be seen a buy.

[brucie5] 30/4/2024 20:28

Just seen it on LSE, thanks. That's huge. 15M sell at 97p.

[bamboo2] 30/4/2024 19:49

Volume 15m. Could seller be finished?

[brucie5] 30/4/2024 16:46

And there go. Sellers seem unwilling to let this go.

[brucie5] 30/4/2024 11:13

Added. Now watch it slip below £1 again.
;)

[tsmith2] 30/4/2024 10:55

Trading update July

[brucie5] 30/4/2024 09:16

Well way I see it, it's started to test likely new support at £.

[tsmith2] 30/4/2024 08:53

buying in if we get reversal on strength here

[takeiteasy] 30/4/2024 06:39

Sounds like more waiting on the next ONT results for confirmation of some sort of stabilisation/start of a demand recovery I suppose for me. The challenge is that the market seems to sometimes appreciate before the results (e.g. OXB) and buying in after a spike changes the risk/reward a bit - the joys of investing in recovery plays :)

[32v31today] 29/4/2024 21:39

One take I had from the recent pacb update was how terrible the end market is / has been. I think it hit them more than others. LSTools seem to have reported a better than expected tough period and looking at things picking up further in H2. This isn't based on a particularly deep dive, but nervousness from pacb will hit ONT. Bottom line for me, hopefully end market is picking up from here. I think Bruce nailed calling these prices a while back. My take is that, long term, this is massively mispriced by the market, and so an opportunity (unless you're dipping in and out every 5 minutes, in which case, who knows) . I'd expect to see the price improve very materially during 2024 (so expect it to go down ;) )My view on current price decline is potentially influenced big holders selling down and end market has been really difficult recently. Both of which have hopefully turned/ turning, both of which are hopefully good for share price. That said I've not done any sums on that.Reasons to buy not sell in my book.

[brucie5] 29/4/2024 18:52

Yes.
;)

[takeiteasy] 29/4/2024 18:24

PACB on Nasdaq on a healthy rise up for once - is this stock specific or is there a reconsideration for this sector underway at all

[brucie5] 26/4/2024 16:59

You could see 1.15 without any change in the chart direction. This is just profoundly oversold, afaic. Don't forget BioMerieux agreed to buy 3.5% at 2.38 last October; and very substantial, recent dir buys at £1 below that.
I see a rare historic opportunity at these levels, but obviously there are risks, so each to their own.
Of three analogous situations I follow: OXB starting to recover - ahead of results on Monday; CWR may also have based out.
As to the 'double bottom' here - yes, very possible, though no telling there might not be a third. Depends if there is another large seller still to come.
Absolutely NAI.

[tsmith2] 26/4/2024 16:12

I'm wanting to see a mover up through £1.05 on good volume before dipping toe

[seball] 26/4/2024 16:08

Double bottom. Technically things are pointing to 150p in short order. Buy

[tsmith2] 26/4/2024 15:27

double bottom?

[seball] 26/4/2024 11:54

Yes I agree once they expire in June things could get very interesting..... BUY